Drug combo breaks down cancer resistance to immunotherapy
By combining a checkpoint inhibitor with a new immunocytokine, scientists at have made a breakthrough in fighting against immunotherapy-resistant cancers.
Materials provided by Ecole Polytechnique Fédérale de Lausanne. Original written by Nik Papageorgiou. Note: Content may be edited for style and length.
Source link aaaaa